Herwig Döllefeld
Chief Executive Officer at Labor für Pharma-und Umweltanalytik GmbH
Profile
Herwig Döllefeld is currently the Managing Director at three different firms: Labor für Pharma-und Umweltanalytik GmbH, Phytos Labor für Analytik von Arzneimitteln GmbH & Co.KG, and GBA Pharma GmbH.
He previously worked as the Co-Managing Director at GBA Gesellschaft für Bioanalytik mbH, Head-Organization at Technische Universität Ilmenau, and Manager-Innovation at X-FAB Semiconductor Foundries GmbH.
He holds a doctorate degree from the University of Hamburg.
Herwig Döllefeld active positions
| Companies | Position | Start |
|---|---|---|
| Labor für Pharma-und Umweltanalytik GmbH | Chief Executive Officer | 01/04/2012 |
| Phytos Labor für Analytik von Arzneimitteln GmbH & Co.KG | Chief Executive Officer | 01/04/2012 |
GBA Pharma GmbH
 GBA Pharma GmbH Pharmaceuticals: MajorHealth Technology GBA Pharma GmbH is a German company that provides preclinical drug development services. The private company is based in Neuried, Germany. The company was founded in 2011. Herwig Döllefeld has been the CEO of the company since 2012. | Chief Executive Officer | 01/04/2012 |
Former positions of Herwig Döllefeld
| Companies | Position | End |
|---|---|---|
X-FAB Semiconductor Foundries GmbH
 X-FAB Semiconductor Foundries GmbH SemiconductorsElectronic Technology X-FAB Semiconductor Foundries AG manufactures silicon wafers for mixed-signal integrated circuits (ICs). It combines modular CMOS and BiCMOS process technologies with service and support during IC development. In addition, from the early product development phase through to batch production, it offers online support, with access to technical documentation and product status on the production lines. The company is headquartered in Erfurt, Germany. | Corporate Officer/Principal | 01/04/2012 |
| Technische Universität Ilmenau | Corporate Officer/Principal | 01/01/2008 |
GBA Gesellschaft für Bioanalytik mbH
 GBA Gesellschaft für Bioanalytik mbH Miscellaneous Commercial ServicesCommercial Services GBA Gesellschaft für Bioanalytik mbH engages in provision of analytical laboratory and consulting services. The firm’s services include environmental analysis, food analysis, GBA pharma and commodities analysis. The company was founded by Erich Döllefeld on June 27, 1989 and is headquartered in Hamburg, Germany. | Chief Executive Officer | - |
Training of Herwig Döllefeld
| University of Hamburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
GBA Gesellschaft für Bioanalytik mbH
GBA Gesellschaft für Bioanalytik mbH Miscellaneous Commercial ServicesCommercial Services GBA Gesellschaft für Bioanalytik mbH engages in provision of analytical laboratory and consulting services. The firm’s services include environmental analysis, food analysis, GBA pharma and commodities analysis. The company was founded by Erich Döllefeld on June 27, 1989 and is headquartered in Hamburg, Germany. | Commercial Services |
X-FAB Semiconductor Foundries GmbH
X-FAB Semiconductor Foundries GmbH SemiconductorsElectronic Technology X-FAB Semiconductor Foundries AG manufactures silicon wafers for mixed-signal integrated circuits (ICs). It combines modular CMOS and BiCMOS process technologies with service and support during IC development. In addition, from the early product development phase through to batch production, it offers online support, with access to technical documentation and product status on the production lines. The company is headquartered in Erfurt, Germany. | Electronic Technology |
| Labor für Pharma-und Umweltanalytik GmbH | |
| Phytos Labor für Analytik von Arzneimitteln GmbH & Co.KG | |
GBA Pharma GmbH
GBA Pharma GmbH Pharmaceuticals: MajorHealth Technology GBA Pharma GmbH is a German company that provides preclinical drug development services. The private company is based in Neuried, Germany. The company was founded in 2011. Herwig Döllefeld has been the CEO of the company since 2012. | Health Technology |
- Stock Market
- Insiders
- Herwig Döllefeld
